A Rare Case of Chemical Peritonitis Following Intravesical Botulinum A Injection for Detusor Overactivity
Journal: Journal of Gynecological Research and Obstetrics (Vol.2, No. 1)Publication Date: 2016-12-21
Authors : Samantha Crowther Subhash Garikipati; Anu Bondili;
Page : 038-038
Keywords : Chemical peritonitis; Botulinum A;
Abstract
A 72 year old lady attended for elective administration of intravesical Botulinum A toxin (Botox 200iu) injections, as a daycase procedure, for the treatment of detrusor over activity. The procedure was undertaking without any complications. A few hours after the operation the patient developed severe constant generalized abdominal pain and distension. There were no other associated features. She underwent a computerized tomography (CT) scan of her abdomen and pelvis which was normal, followed by a Cystogram which was also normal. The only abnormal finding was that of an elevated CRP (380 mg/L). She was treated empirically with intravenous Cefuroxime and Metronidazole for twenty-four hours. Her symptoms slowly resolved and she was discharged home on the 3rd post-operative day with oral antibiotics. She experienced no further complications. Although the exact cause of her symptoms was not found, the timing of this complication means it is highly probable to be due to the intravesical Botox injection. Given the above findings, the most likely diagnosis is that chemical peritonitis. This has not previously been reported in the literature as a side effect of intravesical Botox.
Other Latest Articles
- Prediction of Ovarian Response by Antimullerian Hormone in Women with Polycystic Ovarian Syndrome: A Randomized Prospective Study
- A Novel Method of Selective Chromopertubation at Office Hysteroscopy
- Validity of Hysteroscopy in Detection of Uterine Cavity Abnormalities in Women with Recurrent Pregnancy Loss
- The Accuracy of Prediction of Birth Weight by Automated Measurement of Fetal Long Bones Using 5D Long Bone versus VOCAL 3D and Conventional 2D Weight Formulae
- Co 2 Laser Treatment for Vaginal Intraepithelial Neoplasia, Assesment of Recurrence
Last modified: 2018-09-26 16:14:32